Aprepitant and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Aprepitant and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant-Moxifloxacin
- Aprepitant-Moxifloxacin (Systemic)
- Aprepitant-Moxifloxacin Hydrochloride
- Aprepitant-Moxifloxacin Injection
- Aprepitant-Moxifloxacin Intravenous
- Aprepitant-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Aprepitant Capsules
- Moxetumomab pasudotox-tdfk Intravenous-Aprepitant Injection
- Moxetumomab pasudotox-tdfk Intravenous-Aprepitant Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Aprepitant Oral Suspension
- Moxetumomab pasudotox-tdfk Intravenous-Aprepitant/Fosaprepitant Dimeglumine
- Moxetumomab pasudotox-tdfk Intravenous-Apresazide